The clinical trials landscape in Europe is undergoing significant transformation in 2025. A convergence of regulatory updates, digital harmonization, and...

Biotechnology is entering a new era one where the fusion of life sciences and artificial intelligence (AI) is accelerating discovery,...

In the rapidly evolving life sciences sector, speed and scale often determine success. The pressure to deliver novel solutions, shorten...

As cannabinoid-based pharmaceuticals move from fringe therapy to mainstream treatment, a new class of biopharmaceutical innovators is capturing attention from...

Cannabis-based medicine has rapidly evolved from a controversial topic to a scientifically supported and regulated therapeutic option. Among its most...

Cannabis-based medicine has entered the scientific and regulatory mainstream, with epilepsy at the forefront of its therapeutic promise. High-CBD, low-THC...